
Dream suppression: Difference between revisions
>Josikins m Grammatics |
>Josikins m added 2 citations |
||
Line 2: | Line 2: | ||
'''Dream suppression''' can be described as a suppression of the vividness, intensity, frequency, and recollection of one's dreams. At its lower levels, this can be a partial suppression which results in one having dreams of a lesser intensity and a lower rate of frequency. However, at its higher levels, this can be a complete suppression which results in one not experiencing any dreams at all. | '''Dream suppression''' can be described as a suppression of the vividness, intensity, frequency, and recollection of one's dreams. At its lower levels, this can be a partial suppression which results in one having dreams of a lesser intensity and a lower rate of frequency. However, at its higher levels, this can be a complete suppression which results in one not experiencing any dreams at all. | ||
In the context of psychoactive substance usage, this effect can occur when certain compounds are ingested before a person sleeps. It is most commonly experienced under the influence of [[cannabis]] and other [[cannabinoids]]. This is due to the way in which they | In the context of psychoactive substance usage, this effect can occur when certain compounds are ingested before a person sleeps. It is most commonly experienced under the influence of [[cannabis]] and other [[cannabinoids]]. This is due to the way in which they reduce REM sleep,<ref>Effect of illicit recreational drugs upon sleep: cocaine, ecstasy and marijuana (ncbi) | https://www.ncbi.nlm.nih.gov/pubmed/18313952</ref><ref>Effects of high dosage delta-9-tetrahydrocannabinol on sleep patterns in man (ncbi) | https://www.ncbi.nlm.nih.gov/pubmed/164314</ref> the phase of sleep in which most dreams occur. | ||
</onlyinclude> | </onlyinclude> | ||
===Psychoactive substances=== | ===Psychoactive substances=== | ||
Line 14: | Line 14: | ||
*[[Dissociatives#Subjective_effects|Dissociatives - Subjective effects]] | *[[Dissociatives#Subjective_effects|Dissociatives - Subjective effects]] | ||
*[[Deliriants#Subjective_effects|Deliriants - Subjective effects]] | *[[Deliriants#Subjective_effects|Deliriants - Subjective effects]] | ||
===References=== | |||
<references/> | |||
[[Category:Cognitive]] [[Category:Suppression]] [[Category:Effect]] | [[Category:Cognitive]] [[Category:Suppression]] [[Category:Effect]] |
Revision as of 22:54, 18 October 2017
Dream suppression can be described as a suppression of the vividness, intensity, frequency, and recollection of one's dreams. At its lower levels, this can be a partial suppression which results in one having dreams of a lesser intensity and a lower rate of frequency. However, at its higher levels, this can be a complete suppression which results in one not experiencing any dreams at all.
In the context of psychoactive substance usage, this effect can occur when certain compounds are ingested before a person sleeps. It is most commonly experienced under the influence of cannabis and other cannabinoids. This is due to the way in which they reduce REM sleep,[1][2] the phase of sleep in which most dreams occur.
Psychoactive substances
Compounds within our psychoactive substance index which may cause this effect include:
- 5F-AKB48
- 5F-PB-22
- AB-FUBINACA
- APICA
- Alprazolam
- Amphetamine
- Benzodiazepines
- Bromazepam
- Cannabis
- Clonazepam
- Clonazolam
- Diazepam
- Diclazepam
- Etizolam
- Flubromazepam
- Flubromazolam
- Flunitrazepam
- Flunitrazolam
- JWH-018
- JWH-073
- MDEA
- MDMA
- Memantine
- Nifoxipam
- PMA
- PMMA
- STS-135
- Selective serotonin reuptake inhibitor
- THJ-018
- THJ-2201
See also
- Responsible use
- Subjective effects index
- Dream potentiation
- Psychedelics - Subjective effects
- Dissociatives - Subjective effects
- Deliriants - Subjective effects
References
- ↑ Effect of illicit recreational drugs upon sleep: cocaine, ecstasy and marijuana (ncbi) | https://www.ncbi.nlm.nih.gov/pubmed/18313952
- ↑ Effects of high dosage delta-9-tetrahydrocannabinol on sleep patterns in man (ncbi) | https://www.ncbi.nlm.nih.gov/pubmed/164314